Social deprivation and kidney failure due to an undiagnosed nephropathy.

European deprivation index mediation analysis social deprivation unknown nephropathy

Journal

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
ISSN: 1460-2385
Titre abrégé: Nephrol Dial Transplant
Pays: England
ID NLM: 8706402

Informations de publication

Date de publication:
14 Aug 2023
Historique:
medline: 15 8 2023
pubmed: 15 8 2023
entrez: 14 8 2023
Statut: aheadofprint

Résumé

In France, kidney diseases of undetermined origin account for 5 to 20% of all causes of end-stage kidney disease. We investigated the impact of social disadvantage on the lack of aetiological diagnosis of nephropathies. Data from patients who started dialysis in France between January 1, 2017, and June 30, 2018, were extracted from the French Renal Epidemiology and Information Network registry. The social deprivation of each individual was estimated by the EDI (European Deprivation Index) defined by the patient's address. Logistic regression was used to perform mediation analysis to study the potential association between social deprivation and unknown nephropathy. Of the 7218 patients included, 1263 (17.5%) had unknown kidney disease. A total of 394 (31.4%) patients in the unknown kidney disease belonged to the most deprived quintile of the EDI (Q5), vs. 1636 (27.5%) patients in the known kidney disease group. In the multivariate analysis, unknown kidney disease was associated with Q5 (OR 1.40 [95% CI: 1.12-1.74], p = 0.003). Mediation analysis did not identify any variables (e.g. obesity, initiation of dialysis in emergency, number of visits to the general practitioner and nephrologist before initiation of dialysis, date of first nephrology consultation) that mediated the association between social deprivation and nephropathy of unknown origin. Our results show that, compared with nondeprived subjects, individuals experiencing social deprivation have a higher risk of unknown nephropathy at dialysis initiation. However, mediation analysis did not identify any variables that explained the association between social deprivation and nephropathy of unknown origin.

Sections du résumé

BACKGROUND BACKGROUND
In France, kidney diseases of undetermined origin account for 5 to 20% of all causes of end-stage kidney disease. We investigated the impact of social disadvantage on the lack of aetiological diagnosis of nephropathies.
METHODS METHODS
Data from patients who started dialysis in France between January 1, 2017, and June 30, 2018, were extracted from the French Renal Epidemiology and Information Network registry. The social deprivation of each individual was estimated by the EDI (European Deprivation Index) defined by the patient's address. Logistic regression was used to perform mediation analysis to study the potential association between social deprivation and unknown nephropathy.
RESULTS RESULTS
Of the 7218 patients included, 1263 (17.5%) had unknown kidney disease. A total of 394 (31.4%) patients in the unknown kidney disease belonged to the most deprived quintile of the EDI (Q5), vs. 1636 (27.5%) patients in the known kidney disease group. In the multivariate analysis, unknown kidney disease was associated with Q5 (OR 1.40 [95% CI: 1.12-1.74], p = 0.003). Mediation analysis did not identify any variables (e.g. obesity, initiation of dialysis in emergency, number of visits to the general practitioner and nephrologist before initiation of dialysis, date of first nephrology consultation) that mediated the association between social deprivation and nephropathy of unknown origin.
CONCLUSIONS CONCLUSIONS
Our results show that, compared with nondeprived subjects, individuals experiencing social deprivation have a higher risk of unknown nephropathy at dialysis initiation. However, mediation analysis did not identify any variables that explained the association between social deprivation and nephropathy of unknown origin.

Identifiants

pubmed: 37580138
pii: 7242559
doi: 10.1093/ndt/gfad174
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the ERA.

Auteurs

Hamza Sakhi (H)

Assistance Publique des Hôpitaux de Paris (AP-HP), Department of Nephrology, Dialysis and Transplantation, CHU Necker, Paris, France.

Mathilde Beaumier (M)

Centre Universitaire des maladies rénales, CHU de Caen Normandie, Caen, France.

Cécile Couchoud (C)

REIN Registry, Biomedecine Agency, Saint-Denis-La-Plaine, France.

Mathilde Prezelin-Reydit (M)

Maison du Rein AURAD Aquitaine, Gradignan, France.
Université de Bordeaux, INSERM, CIC1401-EC, Bordeaux, France.

Jennifer Radenac (J)

Filière ORKiD (Orphan Rare Kidney Disease), CHU de Montpellier, Montpellier, France.

Thierry Lobbedez (T)

Centre Universitaire des maladies rénales, CHU de Caen Normandie, Caen, France.

Denis Morin (D)

Filière ORKiD (Orphan Rare Kidney Disease), CHU de Montpellier, Montpellier, France.
Department of Pediatric Nephrology and Endocrinology, CHU de Montpellier, Montpellier, France.

Vincent Audard (V)

Filière ORKiD (Orphan Rare Kidney Disease), CHU de Montpellier, Montpellier, France.
AP-HP, Department of Nephrology and Transplantation, Henri Mondor Hospital University, Centre de Référence Maladie Rare « Syndrome Néphrotique Idiopathique », Fédération Hospitalo-Universitaire « Innovative therapy for immune disorders, Créteil, France.
Université Paris Est Créteil, Institut National de la Santé et de la Recherche Médicale (INSERM) U955, Institut Mondor de Recherche Biomédicale (IMRB), Créteil, France.

Valérie Chatelet (V)

Centre Universitaire des maladies rénales, CHU de Caen Normandie, Caen, France.

Classifications MeSH